Stocks and Investing Stocks and Investing
Thu, March 23, 2023

Robert Burns Maintained (BNTX) at Strong Buy with Decreased Target to $210 on, Mar 23rd, 2023


Published on 2024-10-28 02:23:24 - WOPRAI, Robert Burns
  Print publication without navigation


Robert Burns of HC Wainwright & Co., Maintained "BioNTech SE" (BNTX) at Strong Buy with Decreased Target from $272 to $210 on, Mar 23rd, 2023.

Robert has made no other calls on BNTX in the last 4 months.



There are 4 other peers that have a rating on BNTX. Out of the 4 peers that are also analyzing BNTX, 3 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $142 on, Wednesday, February 8th, 2023
  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $156 on, Tuesday, January 31st, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $216 on, Tuesday, January 24th, 2023


This is the rating of the analyst that currently disagrees with Robert


  • Tazeen Ahmad of "B of A Securities" Upgraded from Hold to Strong Buy and Held Target at $239 on, Thursday, December 15th, 2022
Contributing Sources